JP2011102299A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011102299A5 JP2011102299A5 JP2010262852A JP2010262852A JP2011102299A5 JP 2011102299 A5 JP2011102299 A5 JP 2011102299A5 JP 2010262852 A JP2010262852 A JP 2010262852A JP 2010262852 A JP2010262852 A JP 2010262852A JP 2011102299 A5 JP2011102299 A5 JP 2011102299A5
- Authority
- JP
- Japan
- Prior art keywords
- oligopeptide
- composition according
- positive
- ability
- ifn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010038807 Oligopeptides Proteins 0.000 claims 25
- 102000015636 Oligopeptides Human genes 0.000 claims 25
- 239000000203 mixture Substances 0.000 claims 16
- 210000004027 cells Anatomy 0.000 claims 14
- 239000000725 suspension Substances 0.000 claims 8
- 102100016020 IFNG Human genes 0.000 claims 7
- 101700086956 IFNG Proteins 0.000 claims 7
- 230000004044 response Effects 0.000 claims 7
- 239000002671 adjuvant Substances 0.000 claims 6
- 230000000240 adjuvant Effects 0.000 claims 5
- 238000006243 chemical reaction Methods 0.000 claims 5
- 238000000338 in vitro Methods 0.000 claims 5
- 239000006228 supernatant Substances 0.000 claims 5
- 210000003819 Peripheral blood mononuclear cell Anatomy 0.000 claims 4
- 125000000539 amino acid group Chemical group 0.000 claims 4
- 230000002588 toxic Effects 0.000 claims 4
- 231100000331 toxic Toxicity 0.000 claims 4
- 239000003981 vehicle Substances 0.000 claims 4
- 239000000969 carrier Substances 0.000 claims 3
- 102000037240 fusion proteins Human genes 0.000 claims 3
- 108020001507 fusion proteins Proteins 0.000 claims 3
- 229920002469 poly(p-dioxane) polymer Polymers 0.000 claims 3
- 210000004369 Blood Anatomy 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- 229920001850 Nucleic acid sequence Polymers 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 102000038129 antigens Human genes 0.000 claims 2
- 108091007172 antigens Proteins 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 201000009910 diseases by infectious agent Diseases 0.000 claims 2
- 101700053622 esxA Proteins 0.000 claims 2
- 230000004927 fusion Effects 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 239000000463 material Substances 0.000 claims 2
- 229940035032 monophosphoryl lipid A Drugs 0.000 claims 2
- 150000007523 nucleic acids Chemical group 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 201000008827 tuberculosis Diseases 0.000 claims 2
- 108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 238000002965 ELISA Methods 0.000 claims 1
- 108010065805 Interleukin-12 Proteins 0.000 claims 1
- 108010002350 Interleukin-2 Proteins 0.000 claims 1
- 210000004470 MDP Anatomy 0.000 claims 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims 1
- 229940010383 Mycobacterium tuberculosis Drugs 0.000 claims 1
- 206010070834 Sensitisation Diseases 0.000 claims 1
- 210000002966 Serum Anatomy 0.000 claims 1
- 210000003491 Skin Anatomy 0.000 claims 1
- 210000000952 Spleen Anatomy 0.000 claims 1
- 210000001744 T-Lymphocytes Anatomy 0.000 claims 1
- UZQJVUCHXGYFLQ-AYDHOLPZSA-N [(2S,3R,4S,5R,6R)-4-[(2S,3R,4S,5R,6R)-4-[(2R,3R,4S,5R,6R)-4-[(2S,3R,4S,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-6-(hy Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@@]1(C=O)C)C)(C)CC(O)[C@]1(CCC(CC14)(C)C)C(=O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O[C@H]4[C@@H]([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UZQJVUCHXGYFLQ-AYDHOLPZSA-N 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 102000004965 antibodies Human genes 0.000 claims 1
- 108090001123 antibodies Proteins 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 230000004663 cell proliferation Effects 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- PSLWZOIUBRXAQW-UHFFFAOYSA-M dimethyl(dioctadecyl)azanium;bromide Chemical group [Br-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC PSLWZOIUBRXAQW-UHFFFAOYSA-M 0.000 claims 1
- 239000006185 dispersion Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000002209 hydrophobic Effects 0.000 claims 1
- 230000001900 immune effect Effects 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 239000007791 liquid phase Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- BSOQXXWZTUDTEL-ZUYCGGNHSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-ZUYCGGNHSA-N 0.000 claims 1
- 238000010647 peptide synthesis reaction Methods 0.000 claims 1
- 239000012071 phase Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 230000008313 sensitization Effects 0.000 claims 1
- 230000001235 sensitizing Effects 0.000 claims 1
- 239000007790 solid phase Substances 0.000 claims 1
- 238000005063 solubilization Methods 0.000 claims 1
- 230000000638 stimulation Effects 0.000 claims 1
- 239000000375 suspending agent Substances 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 230000002194 synthesizing Effects 0.000 claims 1
- 230000000699 topical Effects 0.000 claims 1
- 238000005429 turbidity Methods 0.000 claims 1
- 229960005486 vaccines Drugs 0.000 claims 1
- 238000001262 western blot Methods 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA199901020 | 1999-07-13 | ||
| DKPA199901020 | 1999-07-13 | ||
| US14401199P | 1999-07-15 | 1999-07-15 | |
| US60/144,011 | 1999-07-15 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001509760A Division JP5010079B2 (ja) | 1999-07-13 | 2000-07-13 | マイコバクテリウム・ツベルクローシスｅｓａｔ−６遺伝子ファミリーベースの結核ワクチン及び診断法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011102299A JP2011102299A (ja) | 2011-05-26 |
| JP2011102299A5 true JP2011102299A5 (fr) | 2012-06-07 |
| JP5075969B2 JP5075969B2 (ja) | 2012-11-21 |
Family
ID=44192802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010262852A Expired - Fee Related JP5075969B2 (ja) | 1999-07-13 | 2010-11-25 | マイコバクテリウム・ツベルクローシスｅｓａｔ−６遺伝子ファミリーベースの結核ワクチン及び診断法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5075969B2 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3084442T (lt) * | 2013-12-16 | 2021-07-12 | Statens Serum Institut | Diagnostiniai reagentai, skirti pagerintai in vivo arba in vito ląstelių medijuojamai imunologinei tuberkuliozės diagnozei |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6555653B2 (en) * | 1997-05-20 | 2003-04-29 | Corixa Corporation | Compounds for diagnosis of tuberculosis and methods for their use |
-
2010
- 2010-11-25 JP JP2010262852A patent/JP5075969B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4764445B2 (ja) | 結核の免疫治療および診断のための化合物およびそれらの使用方法 | |
| AU2005201767B2 (en) | Tuberculosis vaccine and diagnostics based on the Mycobacterium tuberculosis esat-6 gene family | |
| WO2001079274A2 (fr) | Antigenes de la tuberculose | |
| WO2004006952A2 (fr) | Vaccin therapeutique contre la tuberculose | |
| Roche et al. | Human T‐cell epitopes on the Mycobacterium tuberculosis secreted protein MPT64 | |
| JP2001515359A5 (fr) | ||
| JP2003510018A5 (fr) | ||
| EP1810033A2 (fr) | Glycopetides immunogenes pour le diagnostic d'infections par des micro-organismes pathogenes | |
| WO2005061534A2 (fr) | Vaccins antituberculeux ameliores | |
| JP4820489B2 (ja) | ヒト型結核菌により発現され且つｂｃｇによって発現されないタンパク質、ならびに診断薬およびワクチンとしてのそれらの使用 | |
| WO2013075608A1 (fr) | Antigène recombiné chimère et application associée | |
| US7658929B2 (en) | Immunogenic glycopeptides, screening, preparation and uses | |
| WO2003093307A2 (fr) | Antigenes mycobacteriels et leurs utilisations | |
| US6596281B1 (en) | Mycobacterium tuberculosis specific proteins and genes, mixtures of antigens and uses thereof | |
| WO1991014448A1 (fr) | Nouvelles proteines, nouveaux peptides, et nouvelles sequences d'adn ou d'arn correspondantes et sondes utilisees dans le diagnostic de la tuberculose | |
| KR20160097325A (ko) | 결핵의 개선된 생체내 또는 시험관내 세포-매개 면역학적 진단을 위한 진단 시약 | |
| US20040013685A1 (en) | Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis | |
| JP2011102299A5 (fr) | ||
| Parkash | Serological detection of leprosy employing Mycobacterium leprae derived serine-rich 45 kDa, ESAT-6, CFP-10 and PGL-I: a compilation of data from studies in Indian populations | |
| CN107530414B (zh) | 区分活动性结核病和潜伏结核感染的结核分枝杆菌抗原及其应用 | |
| AU2012202486B2 (en) | Tuberculosis vaccine and diagnostics based on the Mycobacterium tuberculosis esat-6 gene family | |
| IE904536A1 (en) | New methods for diagnosis of tuberculosis | |
| US20080293620A1 (en) | Immunogenic Glycopeptides for Diagnosing Pathogenic Microorganisms Infections | |
| EP1809658B1 (fr) | Peptides antigeniques |